This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
However, whether immediate blood glucose and FIB levels affect coronary blood flow during primary percutaneous coronary intervention (PCI) remains unclear.ObjectiveTo explore the correlation between admission blood glucose (ABG), fibrinogen (FIB) and slow blood flow during primary PCI for acute ST segment elevation myocardialinfarction (STEMI).MethodsA
The paucity of data necessitates further research to elucidate the pathophysiological connection between depression and cardiac diseases in the presence of N-terminal pro-brain natriuretic peptide (NT-proBNP). In addition, three studies found that age and female gender were significant riskfactors in depressed patients.
Patients with acute myocardialinfarction (AMI) complicated by cardiogenic shock (CS) face high mortality rates. Extracorporeal Membrane Oxygenation (ECMO) therapy offers critical support in these cases, yet i.
Type 2 diabetes has traditionally been a riskfactor for worse prognosis after myocardialinfarction (MI), but major advances have been made in its treatment, and the use of secondary preventive measures has i.
Background and objectives Hypertension is one of the most serious riskfactors and the leading cause of mortality in patients with cardiovascular diseases (CVDs). Methods The synopsis of our research is as follows. It is necessary to accurately predict the mortality of patients suffering from CVDs with hypertension.
The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardialinfarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.
IntroductionHypoxic liver injury (HLI) and Killip classification are poor prognostic factors in patients with ST-segment elevation myocardialinfarction (STEMI).
BackgroundCurrent research suggests that microvascular obstruction (MVO) following the first percutaneous coronary intervention (PCI) in myocardialinfarction patients is closely related to inflammatory responses. However, the relationship between LCR and MVO remains unclear.
Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascular riskfactors in patients with hemophilia compared to the general population.
The International Registry of MitraClip in Acute Mitral Regurgitation following Acute MyocardialInfarction (IREMMI). Methods and results The International Registry of MitraClip in Acute Mitral Regurgitation following Acute MyocardialInfarction (IREMMI) includes 187 patients with severe MR post-MI managed with TEER.
The Lasso regression was used to preliminarily screen potential riskfactors, which were entered into the multivariable logistic regression analysis to identify preoperative independent riskfactors for postoperative AKI. Results220 patients (36.2%) developed AKI after surgery. and 63.4%, respectively.
Background Despite advances in percutaneous coronary intervention (PCI) for ST segment elevation myocardialinfarction (STEMI), in-hospital mortality remains a concern, highlighting the need for the identification of additional riskfactors such as serum iron levels. μmol/L) and a control group (Fe ≥7.8 μmol/L).
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.
Myocardialinfarction (MI) with non-obstructive coronary arteries (MINOCA) covers an expanding group of patients over recent years. Previous studies showed considerable risks of outcomes in this group. We performed the Cox regression analysis to investigate the riskfactors for mortality.
Purpose Construction of a prediction model to predict the risk of major adverse cardiovascular events (MACE) in the long term after percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardialinfarction (STEMI).
Contemporary research studies of MINOCA have evaluated the prognosis of these patients, reporting a 12-month all-cause mortality of 4.7% (95% confidence interval, 2.6–6.9), Contemporary research studies of MINOCA have evaluated the prognosis of these patients, reporting a 12-month all-cause mortality of 4.7% (95% confidence interval, 2.6–6.9),
Background Lipoprotein(a) [Lp(a)] is an independent riskfactor for cardiovascular disease due to its unique apo(a) component and its association with atherosclerosis and thrombogenesis. In terms of safety, there was no increased risk of adverse reactions other than injection site reactions.
Background:Prior research has identified a strong relationship between individual personality characteristics and prehospital delay in acute myocardialinfarction. Stroke, Volume 56, Issue Suppl_1 , Page AWP296-AWP296, February 1, 2025. All analyses were performed in R version 4.1.1.Results:183 Male, median NIHSS 2).
Introduction Hypertension is the leading modifiable riskfactor for cardiovascular disease and is implicated in half of all strokes and myocardialinfarctions. One-third of the adults in Scotland have hypertension yet only a quarter of them have their blood pressure (BP) controlled to target (<140/90 mm Hg).
MNPs are emerging as a potential riskfactor for cerebrovascular events such as myocardialinfarction and stroke in recent clinical study. Future research should evaluate the long-term outcomes and the mechanisms by which microplastics and nanoplastics exacerbate the ischemic stroke.
MINOCA: MyocardialInfarction in the Absence of Obstructive Coronary Artery Disease). If there is any evidence of atherosclerosis, modifiable CAD riskfactors should be treated aggressively. Additional research about MINOCA is needed to determine the efficacy of medications aimed at secondary prevention of AMI.
She had zero CAD riskfactors. The first troponin I returned at 0.022 ng/mL (99% URL = 0.030 ng/mL) Not having seen the ECG findings, the providers discussed her very low risk with her and whether she would like to go home and follow up if her 2nd troponin remained negative , or be admitted to observation. Int J Cardiol.
There are numerous other conditions leading to this kind of damage, which can trigger thrombus formation, causing strokes and myocardialinfarctions. The thrombogenic can explain a number of causal riskfactors that do not fit within the LDL-cholesterol hypothesis, including type II diabetes, smoking and systemic lupus erythematosus.
IntroductionAcute coronary syndrome refers to a group of diseases characterized by sudden, decreased blood supply to the heart muscle that results in cell death, also known as acute myocardialinfarction. Hypertension and diabetes were the two most common riskfactors identified. were male, with the average age of 56.313.5
Explore the growing burden of CVD, the rise of new riskfactors, and barriers to prevention: The Rising Global Burden of Cardiovascular Disease CVD is now the leading cause of death worldwide, with low- and middle-income countries (LMICs) experiencing the highest burden.
Uppsala University and Karolinska Institutet researchers have identified 45 proteins in the blood that are associated with the risk of myocardialinfarction (MI), commonly known as a heart attack.
mg tablet), ananti-inflammatory atheroprotective cardiovascular treatment, to reduce the risk of myocardialinfarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple riskfactors for cardiovascular disease.
In an original investigation presented at the Cardiology Research Technology conference in Washington, D.C. Smith Center for Outcomes Research in Cardiology and section chief of Interventional Cardiology at BIDMC. Yeh , MD, MSc, MBA, director of the Richard A. and Susan F. percent). “The
A similar bimodal circadian rhythm pattern was observed in subgroups of patients with STEMI defined with respect to day of the week, age, sex, and coronary riskfactors. BackgroundThe peak incidence of cardiovascular diseases (CVD) usually occurs in the morning.
The profound link between the heart and mind has been the subject of much research for some time, with newer studies reinforcing the existing evidence as well as offering deeper insights. As we step into American Heart Month, it becomes imperative to delve into the intricacies of this relationship and dissect the latest research findings.
2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. 6 Learn more about Biosense Webster's PFA research and clinical evidence here. Circulation Research. Benjamin EJ, Schnabel RB. Epidemiology of Atrial Fibrillation in the 21st Century. 2020 June;127(1):4-20. doi: 10.1161/CIRCRESAHA.120.316340
However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. The study enrolled 6,522 people treated for acute myocardialinfarction at 451 centers in 22 countries. Researchers tracked outcomes for a median of just under 18 months.
They will also selectively support clinical research involving the CaRi-Heart technology for coronary inflammation diagnostics and LODOCO 0.5 Caristo shares Agepha Pharma’s passion for fighting coronary inflammation, which is one of the primary drivers of heart attack risks,” said Frank Cheng , CEO of Caristo Diagnostics.
mg tablet), ananti-inflammatory atheroprotective cardiovascular treatment, to reduce the risk of myocardialinfarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple riskfactors for cardiovascular disease.
Background Sepsis is associated with an increased risk of adverse cardiovascular events in a magnitude comparable to other major cardiovascular riskfactors. We conducted a scoping review to map existing evidence and identify research gaps relating to cardiovascular dysfunction following sepsis.
3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardialinfarction (MI), stroke, and cardiovascular (CV) death.4 7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11
While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24, 24, being held in Atlanta, GA.
The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at ACC.24, Other studies have shown that high levels of HDL cholesterol are associated with reduced heart attack risk.
The purpose was to (i) identify riskfactors for cardiovascular death (CVD) in control patients with HFrEF in the DREAM-HF trial, and (ii) determine if MPCs improve major clinical outcomes (CVD, myocardialinfarction [MI], stroke) in high-risk patients with ischaemic HFrEF and inflammation.
Hyperhomocysteinemia (HHcy) promotes insulin resistance and has also been regarded as a potential riskfactor for cardiovascular disease. BackgroundThe prognostic value of triglyceride-glucose (TyG) has been well described in patients with coronary artery disease (CAD).
Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major riskfactor for cardiometabolic disease. There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or riskfactors such as hypertension and dyslipidemia. [1]
milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.
The connection between heart health, vascular riskfactors, and sexual function is well-documented, with poor cardiovascular health often leading to or exacerbating erectile issues. Factors such as age, severity of heart disease, riskfactors, and lifestyle choices (such as smoking and diet) can all influence the outcome.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content